• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.60% Nasdaq Down0.39%

    IsoRay, Inc. (ISR)

    -NYSE MKT
    0.69 Up 0.06(9.51%) Feb 11, 4:02PM EST
    ProfileGet Profile for:
    IsoRay, Inc.
    350 Hills Street
    Suite 106
    Richland, WA 99354
    United States - Map
    Phone: 509-375-1202
    Fax: 509-375-3473
    Website: http://www.isoray.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Instruments & Supplies
    Full Time Employees:35

    Business Summary 

    IsoRay, Inc. develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds for the treatment of prostate, lung, head and neck, colorectal, brain, pelvic/abdominal, and gynecological cancers, as well as ocular melanoma. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer, including primary and recurrent gliomas and metastic brain tumors. The company was formerly known as Century Park Pictures Corporation and changed its name to IsoRay, Inc. in 2005. IsoRay, Inc. was founded in 1983 and is headquartered in Richland, Washington.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on IsoRay, Inc.

    Key Executives 
     PayExercised
    Mr. William Cavanagh III, 50
    Interim Chief Exec. Officer and VP of R&D
    158.00K7.00K
    Mr. Brien L. Ragle CPA, /CGMA, 47
    Chief Financial Officer
    119.00K0.00
    Ms. Krista Cline , 34
    Corp. Sec.
    N/AN/A
    Dr. Steven M. Kurtzman M.D., 54
    Medical Director
    N/AN/A
    Ms. Patricia Mills ,
    NE Area Sales Director
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders